Halozyme Therapeutics, Inc. revenue breakdown overview

Halozyme Therapeutics, Inc. revenue for the last year amounted to 1.02 B USD, the most of which — 1.02 B USD — came from its highest performing source at the moment, Enzymes and Devices, the year earlier bringing 829.25 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Halozyme Therapeutics, Inc. 690.46 M USD, and the year before that — 587.20 M USD.